Urologix Inc (ULGX.W)

ULGX.W on CBOE When Trading NASDAQ Global Select Market

1.63USD
8 Feb 2010
Price Change (% chg)

$0.02 (+1.23%)
Prev Close
$1.63
Open
--
Day's High
$1.65
Day's Low
$1.61
Volume
12,200
Avg. Vol
24,433
52-wk High
$2.02
52-wk Low
$0.21

ULGX.W

Chart for ULGX.W

About

Urologix, Inc. (Urologix) develops, manufactures and markets non-surgical, catheter-based therapies that use a cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH). The Company markets its control units under the CoolWave and Targis names and its procedure kits under CTC Advance, CTC, Targis and... (more)

Overall

Beta: 1.84
Market Cap (Mil.): $23.90
Shares Outstanding (Mil.): 14.49
Annual Dividend: 0.00
Yield (%): NA

Financials

  ULGX.W Industry Sector
P/E (TTM): -- 6.39 3.76
EPS (TTM): 75.88 -- --
ROI: -34.01 1.18 2.30
ROE: -34.63 1.76 2.82
view overview for:

Latest News about ULGX.W

Urologix Q1 results

UROLOGIX INC : * First quarter loss per share $0.03 * First quarter revenue fell 20 percent to $4.4 million * Reuters Estimates first quarter earnings per share view $-0.03, revenue view $4.97 million

24 Oct 2007

TABLE-Urologix posts Q4 net loss

UROLOGIX INC (in $) Latest Yr-ago qtr EPS (diluted) -0.84 0.32 Net (million) -12.1 4.7 Sales (million) 4.8 6.6 Reuters Estimates: Loss/shr $0.04 (two analysts), revenue $5.4 million (three analysts).

22 Aug 2007
» More ULGX.W News

Competitors

  Price Change
American Medical Systems Holdings, Inc. (AMMD.OQ) $18.33 +0.12
Biolitec AG (BIBG.DE) €3.80 0.00
Abbott Laboratories (ABT.N) $53.35 0.00
Pfizer Inc. (PFE.N) $17.88 +0.04
Sanofi-Aventis SA (SASY.PA) €52.99 +0.33
Merck & Co., Inc. (MRK.N) $36.47 -0.12
GlaxoSmithKline plc (GSK.L) £1,203.00 -15.50
Boston Scientific Corporation (BSX.N) $8.23 +0.08
Medtronic, Inc. (MDT.N) $42.36 +0.57

  Earnings  vs    Estimates

view overview for: